Lewy Body Pathology and Alzheimer Disease in Down Syndrome
نویسندگان
چکیده
Abstract Introduction/Objective Aging adults with Down syndrome (DS) develop Alzheimer disease neuropathology (AD) by the age of 40 years, primarily due to overexpression amyloid precursor protein on chromosome 21. Lewy bodies (LBs), containing alpha-synuclein protein, are observed in 7-60% AD patients amygdala and cortex. Prior DS studies (n=20-56 cases) find frequency LB pathology range between 8-50% cases being affected. We hypothesized that would also be present brain similar locations prevalence AD. Thus, we evaluated our UCI cohort have collected over past 25 years. Methods/Case Report Neuropathology reports from 55 UCI-ADRC were included this study. Cases stained for beta-amyloid, phosphor-tau, TDP-43 as per NACC protocols (one case each v7,8,9 three v11). Results (if a Case Study enter NA) identified 6 (10.9%), all male, mean 57 years (SD=3) showed and/or neurites. was classified predominant 3 cases, brainstem one, intermediate/transitional diffuse/neocortical one. Five BRAAK stage one 5. had CERAD neuritic plaque score C B score. Two Thal phase 5, 4. The demonstrated hippocampal sclerosis. Conclusion observation positive male may reflect sample bias. In study, most common but other sites involvement seen prior study studies. (10.9%) is low end
منابع مشابه
Alzheimer and Lewy body pathology or Creutzfeldt-Jakob disease.
The objective of this work is to describe the neuropathological findings of a patient clinically presenting with rapidly progressive nonspecific neurological symptoms suggestive of Creutzfeldt-Jakob disease. Methods used were clinical description with laboratory analyses, repeated electroencephalogram, cerebral computed tomography, magnetic resonance imaging studies and details on neuropatholog...
متن کاملCerebrovascular pathology in Down syndrome and Alzheimer disease
People with Down syndrome (DS) are at high risk for developing Alzheimer disease (AD) with age. Typically, by age 40 years, most people with DS have sufficient neuropathology for an AD diagnosis. Interestingly, atherosclerosis and hypertension are atypical in DS with age, suggesting the lack of these vascular risk factors may be associated with reduced cerebrovascular pathology. However, becaus...
متن کاملLewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.
BACKGROUND The origin and significance of Lewy bodies and neurites (Lewy body pathology [LBP]) in Alzheimer disease (AD) are poorly understood. OBJECTIVE To examine LBP in the brainstem, limbic cortex, and neocortex of a large number of familial AD cases with mutations in 2 presenilin (PSEN) genes. METHODS Twenty-five familial AD cases with 9 known PSEN 1 mutations and 14 familial AD cases ...
متن کاملGBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
OBJECTIVES Mutations in the GBA gene occur in 7% of patients with Parkinson disease (PD) and are a well-established susceptibility factor for PD, which is characterized by Lewy body disease (LBD) neuropathologic changes (LBDNCs). We sought to determine whether GBA influences risk of dementia with LBDNCs, Alzheimer disease (AD) neuropathologic changes (ADNCs), or both. METHODS We screened the ...
متن کاملCommon inflammatory mechanisms in Lewy body disease and Alzheimer disease.
Cortical Lewy body disease as a cause of dementia has been recognized for more than 40 years. Only in the past 15 to 20 years, however, has the true frequency of this entity come to be appreciated, primarily because of the advent of sensitive and specific immunohistochemical diagnostic techniques. We now know that there is frequent and extensive overlap, both clinically and pathologically, betw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Clinical Pathology
سال: 2022
ISSN: ['0002-9173', '1943-7722']
DOI: https://doi.org/10.1093/ajcp/aqac126.059